Furthermore, clinical studies and genomic analysis have confirmed that LRP6 genetic variants contribute to the progression of hypertension, atherosclerosis, hypercholesterolemia, and other diseases [24,57]. This evidence concerns the gene LRP6 and hypertensive disorder.